A-Med Medical Supply Division has been acquired by Byram Healthcare Centers, Inc.
A-Med Health Care (A-Med) has sold its Medical Supplies Division to Byram Healthcare Centers, Inc. (Byram), a wholly owned subsidiary of Mediq NV. The acquisition represents an EBITDA multiple of approximately 7.5x, excluding synergies.
Founded in 1982 and headquartered in Huntington Beach, California, A-Med is one of the leading distributors of incontinence and urology supplies in the California market serving Medicare, Medicaid / Medi-Cal and managed care patients.
Byram operates as a US subsidiary of Mediq NV, an international company delivering medical devices, pharmaceuticals and related care services. Mediq delivers via three channels: direct to people's homes (Direct), to professional customers such as hospitals, nursing homes and GPs (Institutional) and via Mediq Pharmacies. Mediq operates in 15 countries and has its head office in Utrecht, the Netherlands. This acquisition will establish Byram as a leading provider of medical supplies in the Californian home care market.
A-Med Health Care is a specialty pharmacy providing advanced medications, infusions, supplies, and services to patients living with complex conditions. The company provides support for patients suffering from conditions such as Cystic Fibrosis, HIV/AIDS, Multiple Sclerosis, organ transplants and paraplegia. A-Med Health Care, founded in 1982 and with approximately 200 employees, services patients all across the country.
Oaklins' team in Los Angeles acted as the exclusive financial advisor to A-Med in connection with this asset sale. The transaction was facilitated by Oaklins' team in the Netherlands who identified and contacted Mediq on behalf of the American team. This transaction once again highlights our ability to close deals worldwide.


Talk to the deal team
Gary S. Rabishaw
Oaklins Intrepid
Eduard Bagdasarian
Oaklins Intrepid
Jeremiah Mann
Oaklins Intrepid
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more